MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Capital Expenditures of $272000.0 for Q4 2025, down 55.41% on a QoQ basis from $610000.0 in Q3 2025, and down 77.67% year-over-year from $1.2 million in Q4 2024.
MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Capital Expenditures history runs 9 years deep, the most recent figure standing at $272000.0 for Q4 2025.
- Quarterly Capital Expenditures fell 77.67% year-over-year to $272000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.8 million (down 22.79% YoY) and the FY2025 annual result came in at $3.8 million, down 22.79% from the prior year.
- Capital Expenditures was $272000.0 for Q4 2025 at MeiraGTx Holdings, down from $610000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $44.9 million in Q4 2022 and bottomed at -$26.3 million in Q3 2022.
- A 5-year average of $5.1 million and a median of $2.7 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures plunged 321.33% — and 2025, when it soared 370.57%.
- MeiraGTx Holdings' Capital Expenditures stood at $24.4 million in 2021, then soared by 84.05% to $44.9 million in 2022, then sank by 96.0% to $1.8 million in 2023, then plunged by 32.11% to $1.2 million in 2024, then slumped by 77.67% to $272000.0 in 2025.
- Business Quant data shows MGTX's Capital Expenditures at $272000.0 in Q4 2025, $610000.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - | 272,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 272,000.00 |
| Dec 31, 2025 | 272,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 730,000.00 |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 3.64 Mn |
| Mar 31, 2024 | -632,000.00 |
| Mar 31, 2024 | -632,000.00 |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | -13.57 Mn |
| Sep 30, 2023 | -13.57 Mn |